Myung In Pharm Co., Ltd. logo

Myung In Pharm Co., Ltd. (317450)

Market Open
10 Aug, 06:30
KRX SM KRX SM
48,300. 00
+2,250
+4.886%
686.93B Market Cap
- P/E Ratio
- Div Yield
37,058 Volume
- Eps
46,050
Previous Close
Add Transaction
Day Range
45,900 48,750
Year Range
39,100 134,500
Want to track 317450 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Myung In Pharm Co., Ltd. (317450) Statistics

Valuation metrics

Market Cap 686.93B
Enterprise value 166.08B
Trailing P/E (ttm) 7
Forward P/E -
PEG ratio -
Price/Sales (ttm) 2.38
Price/Book (mrq) -
Enterprise Value/Revenue 0.57
Enterprise Value/EBITDA 1.56

Overview

Shares outstanding 14.6M
Float 2.49M
Shares short -
% Held by insiders 0.76%
% Held by institutions 0.01%
Average volume (10 days) 24.52K
Average volume (90 days) 21.63K

Price summary

52-Week low 39,100
52-Week high 134,500
Beta -
50-Day moving average 54,508
200-Day moving average 66,896.95

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.3%
Operating margin 0.35%

Operational effectiveness

Return on assets 0.1%
Return on equity 0.13%

Income Statement

Revenue (ttm) 289.14B
Revenue per share (ttm) 22,289.43
Quarterly revenue growth (yoy) 0.03%
Gross profit (ttm) 177.32B
EBITDA 119.16B
Net income to common (ttm) 85.53B
Diluted EPS (ttm) 6,718
Quarterly earnings growth (yoy) 0.22%

Balance Sheet

Total cash (mrq) 522.1B
Total cash per share (mrq) 35,762.11
Total debt (mrq) 1.29B
Total Debt/Equity (mrq) 0.16
Current ratio (mrq) 8.85%
Book value per share (mrq) -

Cash Flow

Cash flow statement 89.73B
Levered free cash flow (LFCF) 81.44B